Simplex Trading, LLC Morphic Holding, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$26.12 - $34.07 $28,470 - $37,136	-1,090 Reduced 32.06%	2,310 $78,000
Q1 2024 Apr 25, 2024	BUY	$26.64 - $40.31 $85,594 - $129,516	3,213 Added 1718.18%	3,400 $119,000
Q4 2023 Feb 02, 2024	BUY	$19.95 - $31.0 $3,730 - $5,797	187 New	187 $5,000
Q2 2023 Aug 04, 2023	BUY	$34.33 - $62.11 $30,656 - $55,464	893 Added 4.69%	19,919 $1.14 Million
Q1 2023 Apr 27, 2023	BUY	$26.01 - $48.69 $494,866 - $926,375	19,026 New	19,026 $716,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.